UB23:LSE:LSE-UBS MSCI Canada UCITS CAD A-dis (GBX)

ETF | Others |

Last Closing

USD 3420

Change

+15.00 (+0.44)%

Market Cap

N/A

Volume

365.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+4.25 (+2.21%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-0.04 (-0.03%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.12 (-0.65%)

USD 547.46B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.89%)

USD 547.46B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.70 (-0.97%)

USD 266.08B
0QZO:LSE 0QZO

+0.50 (+0.54%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-1.81 (-1.07%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.20 (-0.64%)

USD 200.79B
0R24:LSE Intel Corp.

+0.65 (+2.93%)

USD 196.14B

ETFs Containing UB23:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.56% 51% F 54% F
Dividend Return 0.01% 11% F 17% F
Total Return 6.57% 49% F 54% F
Trailing 12 Months  
Capital Gain 12.33% 48% F 52% F
Dividend Return 0.01% 12% F 13% F
Total Return 12.35% 46% F 52% F
Trailing 5 Years  
Capital Gain 31.49% 54% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.49% 51% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 8.43% 62% D 66% D+
Dividend Return 8.43% 61% D- 65% D
Total Return 0.00% 6% D- 3% F
Risk Return Profile  
Volatility (Standard Deviation) 13.18% 53% F 69% C-
Risk Adjusted Return 63.99% 72% C 82% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.